- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Wanbury Limited — Board Meeting, 26-06-2026: Outcome of Board Meeting
26-06-2026 | 06:56 pm
26-06-2026 | 06:56 pm
Wanbury Pharma's board approved establishing a new subsidiary, Wanbury Skin Health Ltd, with an initial investment of ₹0.041 Cr for an 82% stake. Ernst & Young LLP was appointed as Internal Auditor, and ABK & Associates as Cost Auditor for FY26-27.
No comments yet. Be the first to comment!